Addus HomeCare (NASDAQ:ADUS) Issues Earnings Results

Addus HomeCare (NASDAQ:ADUS) posted its earnings results on Monday. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03, FiscalAI reports. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million.

Addus HomeCare Stock Up 1.1%

Shares of ADUS traded up $1.31 during midday trading on Monday, hitting $116.79. 248,645 shares of the company’s stock traded hands, compared to its average volume of 245,358. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.18 billion, a price-to-earnings ratio of 21.59, a price-to-earnings-growth ratio of 1.58 and a beta of 0.87. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $124.43. The firm’s fifty day moving average is $101.68 and its 200-day moving average is $101.40.

Insider Transactions at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 788 shares of company stock worth $73,506. Corporate insiders own 4.10% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently modified their holdings of ADUS. Royal Bank of Canada grew its position in Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after purchasing an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after buying an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Addus HomeCare by 6.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC raised its stake in Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after acquiring an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC lifted its position in Addus HomeCare by 44.7% during the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after acquiring an additional 4,439 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ADUS has been the topic of a number of recent research reports. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Citizens Jmp restated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Finally, Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $131.50.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.